Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
S63845
.
Show all posts
Showing posts with label
S63845
.
Show all posts
Thursday, August 3, 2017
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
›
A new compound, discovered jointly by international pharmaceutical company Servier, headquartered in France, and Vernalis (R&D), a com...
Wednesday, August 2, 2017
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
›
A new compound, discovered jointly by international pharmaceutical company Servier, headquartered in France, and Vernalis (R&D), a com...
›
Home
View web version
